Literature DB >> 9776111

Significance of stem cell factor and soluble KIT in patients with systemic lupus erythematosus.

T Kitoh1, H Ishikawa, S Sawada, K Koshino, Y Tokano, H Hashimoto, S Nakagawa.   

Abstract

To determine the significance of stem cell factor (SCF) and soluble KIT (sKIT) in the serum of patients with systemic lupus erythematosus (SLE), levels of SCF and sKIT in patients with SLE were estimated, and their correlations with clinical parameters were examined. The sKIT levels in SLE patients (n = 106) were significantly lower than those in healthy controls (n = 40). A significant negative correlation was found between the SCF and sKIT levels of SLE patients. Although the SCF levels correlated with the titre of anti-RNP antibody, no significant relationship was found between SCF levels and blood cell counts, such as white blood cell, red blood cell and platelet counts. sKIT levels were significantly correlated with the platelet count, and were negatively correlated with the white blood cell count, titre of anti-DNA antibody, and SLE activity index (SLEDAI). sKIT levels were also negatively affected by high doses of corticosteroid. These results indicate that serum sKIT levels may be more closely related than SCF to the haematological abnormalities in SLE patients, and may reflect the clinical status of SLE patients and the effectiveness of high-dose corticosteroid treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9776111     DOI: 10.1007/bf01451008

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  36 in total

1.  The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus.

Authors:  E Huang; K Nocka; D R Beier; T Y Chu; J Buck; H W Lahm; D Wellner; P Leder; P Besmer
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

2.  Identification of a ligand for the c-kit proto-oncogene.

Authors:  D E Williams; J Eisenman; A Baird; C Rauch; K Van Ness; C J March; L S Park; U Martin; D Y Mochizuki; H S Boswell
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

3.  Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera.

Authors:  M Mattioli; M Reichlin
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

4.  c-kit mRNA expression in human and murine hematopoietic cell lines.

Authors:  C André; L d'Auriol; C Lacombe; S Gisselbrecht; F Galibert
Journal:  Oncogene       Date:  1989-08       Impact factor: 9.867

5.  Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells, and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor.

Authors:  I D Bernstein; R G Andrews; K M Zsebo
Journal:  Blood       Date:  1991-06-01       Impact factor: 22.113

6.  Soluble c-kit molecule in serum from healthy individuals and patients with haemopoietic disorders.

Authors:  M Kawakita; Y Yonemura; H Miyake; T Ohkubo; N Asou; K Hayakawa; M Nakamura; T Kitoh; H Osawa; K Takatsuki
Journal:  Br J Haematol       Date:  1995-09       Impact factor: 6.998

7.  Human umbilical vein endothelial cells display high-affinity c-kit receptors and produce a soluble form of the c-kit receptor.

Authors:  V C Broudy; N L Kovach; L G Bennett; N Lin; F W Jacobsen; P G Kidd
Journal:  Blood       Date:  1994-04-15       Impact factor: 22.113

8.  Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines.

Authors:  A M Turner; L G Bennett; N L Lin; J Wypych; T D Bartley; R W Hunt; H L Atkins; K E Langley; V Parker; F Martin
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

9.  Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders.

Authors:  R A Stuart; A J Littlewood; P J Maddison; N D Hall
Journal:  Clin Exp Rheumatol       Date:  1995 Jan-Feb       Impact factor: 4.473

10.  Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus.

Authors:  T Koike; M Sueishi; H Funaki; H Tomioka; S Yoshida
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

View more
  2 in total

1.  Molecularly and clinically related drugs and diseases are enriched in phenotypically similar drug-disease pairs.

Authors:  Ingo Vogt; Jeanette Prinz; Mónica Campillos
Journal:  Genome Med       Date:  2014-08-17       Impact factor: 11.117

2.  Stem cell factor and its soluble receptor (c-kit) in serum of asthmatic patients- correlation with disease severity.

Authors:  Joanna S Makowska; Malgorzata Cieslak; Marek L Kowalski
Journal:  BMC Pulm Med       Date:  2009-06-01       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.